Announced Wed, 24 Jun · 10:20 IST
Trading window closed ahead of June 2026 quarter results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹41.50
prior close
₹41.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-0.2-0.5-1.2-1.6-1.2+0.2-4.5-4.8——
Up moveDown movePending
AI summary
Sandu Pharmaceuticals has closed its trading window from 1 July 2026 until 48 hours after declaring financial results for the quarter ended 30 June 2026. The restriction applies to directors, key managerial personnel, promoters, designated persons and their immediate relatives. The board meeting date to approve the unaudited results will be announced later. This is a routine SEBI-mandated insider trading compliance filing.
Likely market impact
Routine compliance filing; insiders barred from trading until results are declared. No direct impact on retail shareholders.